Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 86, Issue 1 , Pages 3-11 , January 2012

Radiation resistance, invasiveness and metastasis are inflammatory events that could be suppressed by lipoxin A4

  • Undurti N. Das

      Affiliations

    • UND Life Sciences, 13800 Fairhill Road, #321, Shaker Heights, OH 44120, USA
    • School of Biotechnology, Jawaharlal Nehru Technological University, Kakinada 533003, India
    • Bio-Science Research Centre, GVP College of Engineering Campus, Visakhapatnam 530048, India
    • Corresponding Author InformationCorrespondence to: UND Life Sciences, 13800 Fairhill Road, #321, Shaker Heights, OH 44120, USA. Tel.: +1 216 231 5548; fax: +1 928 833 0316.

Received 27 September 2011 ,Accepted 30 September 2011.

References 

  1. Eisen V, Walker DI. Effect of ionizing radiation on prostaglandin-like activity in tissues. Br. J. Pharmacol. 1976;57:527–532
  2. Walker DI, Eisen V. Effect of ionizing radiation on 15-hydroxy prostaglandin dehydrogenase (PGDH) activity in tissues. Int. J. Radiat. Biol. 1979;36:399–407
  3. Trocha PJ, Catravas GN. Prostaglandin levels and lysosomal enzyme activities in irradiated rats. Int. J. Radiat. Biol. 1980;38:503–511
  4. Steel LK, Catravas GN. Radiation-induced changes in production of prostaglandins F2 alpha, E, and thromboxane B2 in guinea pig parenchymal lung tissues. Int. J. Radiat. Biol. 1982;42:517–530
  5. Steel LK, Sweedler IK, Catravas GN. Effects of 60Co radiation on synthesis of prostaglandins F2 alpha, E, and thromboxane B2 in lung airways of guinea pigs. Radiat. Res. 1983;94:156–165
  6. Yamaoka K, Obata T, Iriyama K, Iwasaki T, Hoshi Y. Simultaneous quantitative analysis of prostaglandins and thromboxane after low-dose X irradiation. Radiat. Res. 1998;149:103–106
  7. Steinauer KK, Gibbs I, Ning S, French JN, Armstrong J, Knox SJ. Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells. Int. J. Radiat. Oncol. Biol. Phys. 2000;48:325–328
  8. Tessner TG, Muhale F, Schloemann S, Cohn SM, Morrison AR, Stenson WF. Ionizing radiation up-regulates cyclooxygenase-2 in I407 cells through p38 mitogen-activated protein kinase. Carcinogenesis. 2004;25:37–45
  9. Walden TL, Patchen M, Snyder SL. 16,16-Dimethyl prostaglandin E2 increases survival in mice following irradiation. Radiat. Res. 1987;109:440–448
  10. Hahn GL, Menconi MJ, Cahill M, Polgar P. The influence of gamma radiation on arachidonic acid release and prostacyclin synthesis. Prostaglandins. 1983;25:783–791
  11. Eldor A, Vlodavsky I, HyAm E, Atzmon R, Fuks Z. The effect of radiation on prostacyclin (PGI2) production by cultured endothelial cells. Prostaglandins. 1983;25:263–279
  12. Ts'ao CH, Ward WF, Port CD. Radiation injury in rat lung. I. Prostacyclin (PGI2) production, arterial perfusion, and ultrastructure. Radiat. Res. 1983;96:284–293
  13. Hosoi Y, Yamamoto M, Ono T, Sakamoto K. Prostacyclin production in cultured endothelial cells is highly sensitive to low doses of ionizing radiation. Int. J. Radiat. Biol. 1993;63:631–638
  14. Rhodes LE, Gledhill K, Masoodi M, Haylett AK, Brownrigg M, Thody AJ, et al. The sunburn response in human skin is characterized by sequential eicosanoid profiles that may mediate its early and late phases. FASEB J. 2009;23:3947–3956
  15. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 2008;8:349–361
  16. Romano M. Lipoxin and aspirin-triggered lipoxins. Sci. World J. 2010;10:1048–1064
  17. Zhang B-X, Ma X, Zhang W, Yeh C-K, Lin A, Luo J, et al. Polyunsaturated fatty acids mobilize intracellular Ca2+ in NT2 human teratocarcinoma cells by causing release of Ca2+ from mitochondria. Am J. Physiol. Cell. Physiol. 2006;290:C1321–C1333
  18. N.B. Boneva, T. Yamashima, New insights into “GPR40-CREB interaction in adult neurogenesis” specific for primates. Hippocampus, doi:10.1002/hipo.20951, in press.
  19. Boneva NB, Kikuchi M, Minabe Y, Yamashima T. Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: implication of fatty acid–binding proteins (FABP) and G Protein–Coupled Receptor 40 (GPR40) in adult neurogenesis. J. Pharmacol. Sci. 2011;116:163–172
  20. Das UN. Lipoxins as biomarkers of lupus and other inflammatory conditions. Lipids Health Dis. 2011;10:76
  21. Das UN. Essential fatty acids: biochemistry, physiology, and pathology. Biotech. J. 2006;1:420–439
  22. Das UN. Lipoxins, resolvins, protectins, maresins and nitrolipids: connecting lipids, inflammation, and cardiovascular disease risk. Curr. Cardiovasc. Risk Rep. 2010;4:24–31
  23. Walden TL, Patchen ML, MacVittie TJ. Leukotriene-induced radioprotection of hematopoietic stem cells in mice. Radiat. Res. 1988;113:388–395
  24. Walden TL. Leukotriene C4-induced radioprotection: the role of hypoxia. Radiat. Res. 1992;132:359–367
  25. Walden TL. Radioprotection of mouse hematopoietic stem cells by leukotriene A4 and lipoxin B4. J. Radiat. Res. 1988;29:255–260
  26. Hanson WR, Thomas C. 16, 16-dimethyl prostaglandin E2 increases survival of murine intestinal stem cells when given before photon radiation. Radiat. Res. 1983;96:393–398
  27. Hanson WR, Ainsworth EJ. 16, 16-Dimethyl prostaglandin E2 induces radioprotection in murine intestinal and hematopoietic stem cells. Radiat. Res. 1985;103:196–203
  28. Hanson WR. Radiation protection of murine intestine by WR-2721, 16,16-dimethyl prostaglandin E2, and the combination of both agents. Radiat. Res. 1987;111:361–373
  29. Hanson WR, Grdina DJ. Radiation-induced DNA single-strand breaks in the intestinal mucosal cells of mice treated with the radioprotectors WR-2721 or 16-16 dimethyl prostaglandin E2. Int. J. Radiat. Biol. 1987;52:67–76
  30. Hofer M, Pospísil M, Tkadlecek L, Viklická S, Pipalová I, Holá J. Low survival of mice following lethal gamma-irradiation after administration of inhibitors of prostaglandin synthesis. Physiol. Res. 1992;41:157–161
  31. Kort WJ, Weijma IM, Bijma AM, van Schalkwijk WP, Zijlstra FJ, Westbroek DL. Growth of an implanted fibrosarcoma in rats is associated with high levels of plasma prostaglandin-E2 and thromboxane-B2. Prostaglandins Leukot. Med. 1987;28:25–34
  32. Robertson RP, Baylink DJ, Marini BJ, Adkison HW. Elevated prostaglandins and suppressed parathyroid hormone associated with hypercalcemia and renal cell carcinoma. J. Clin. Endocrinol. Metab. 1975;41:164–167
  33. Hong SL, Wheless CM, Levine L. Elevated prostaglandins synthetase activity in methylcholanthrene-transformed mouse BALB/3T3. Prostaglandins. 1977;13:271–279
  34. Seyberth HW, Hubbard WC, Oelz O, Sweetman BJ, Watson JT, Oates JA. Prostaglandin-mediated hypercalcemia in the VX2 carcinoma-bearing rabbit. Prostaglandins. 1977;14:319–331
  35. Rolland PH, Martin PM, Jacquemier J, Rolland AM, Toga M. Prostaglandin in human breast cancer: evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. J. Natl. Cancer Inst. 1980;64:1061–1070
  36. Trevisani A, Ferretti E, Capuzzo A, Tomasi V. Elevated levels of prostaglandin E2 in Yoshida hepatoma and the inhibition of tumour growth by non-steroidal anti-inflammatory drugs. Br. J. Cancer. 1980;41:341–347
  37. Foecking MK, Kibbey WE, Abou-Issa H, Matthews RH, Minton JP. Hormone dependence of 7,12-dimethylbenz[a]anthracene-induced mammary tumor growth: correlation with prostaglandin E2 content. J. Natl. Cancer Inst. 1982;69:443–446
  38. Young MR, Newby M. Enhancement of Lewis lung carcinoma cell migration by prostaglandin E2 produced by macrophages. Cancer Res. 1986;46:160–164
  39. Vanderveen EE, Grekin RC, Swanson NA, Kragballe K. Arachidonic acid metabolites in cutaneous carcinomas. evidence suggesting that elevated levels of prostaglandins in basal cell carcinomas are associated with an aggressive growth pattern. Arch. Dermatol. 1986;122:407–412
  40. Uefuji K, Ichikura T, Mochizuki H. Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer. Clin. Cancer Res. 2000;6:135–138
  41. Howe LR, Subbaramaiah K, Chung WJ, Dannenberg AJ, Brown AM. Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells. Cancer Res. 1999;59:1572–1577
  42. Subbarayan V, Sabichi AL, Llansa N, Lippman SM, Menter DG. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells. Cancer Res. 2001;61:2720–2726
  43. Liu XH, Kirschenbaum A, Yao S, Stearns ME, Holland JF, Claffey K, et al. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin. Exp. Metastasis. 1999;17:687–694
  44. Giles FJ, Kantarjian HM, Bekele BN, Cortes JE, Faderl S, Thomas DA, et al. Bone marrow cyclooxygenase-2 levels are elevated in chronic-phase chronic myeloid leukaemia and are associated with reduced survival. Br. J. Haematol. 2002;119:38–45
  45. Hansen-Petrik MB, McEntee MF, Jull B, Shi H, Zemel MB, Whelan J. Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice. Cancer Res. 2002;62:403–408
  46. Lim SC, Park SY, Do NY. Correlation of cyclooxygenase-2 pathway and VEGF expression in head and neck squamous cell carcinoma. Oncol. Rep. 2003;10:1073–1079
  47. Gupta RA, Tejada LV, Tong BJ, Das SK, Morrow JD, Dey SK, et al. Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer. Cancer Res. 2003;63:906–911
  48. Sorokin A. Cyclooxygenase-2: potential role in regulation of drug efflux and multidrug resistance phenotype. Curr. Pharm. Des. 2004;10:647–657
  49. Patel VA, Dunn MJ, Sorokin A. Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2. J. Biol. Chem. 2002;277:38915–38920
  50. Puhlmann U, Ziemann C, Ruedell G, Vorwerk H, Schaefer D, Langebrake C, et al. Impact of the cyclooxygenase system on doxorubicin-induced functional multidrug resistance 1 overexpression and doxorubicin sensitivity in acute myeloid leukemic HL-60 cells. J. Pharmacol. Exp. Ther. 2005;312:346–354
  51. Han C, Wu T. Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt. J. Biol. Chem. 2005;280:24053–24063
  52. Chemnitz JM, Driesen J, Classen S, Riley JL, Debey S, Beyer M, et al. Prostaglandin E2 impairs CD4+ T cell activation by inhibition of lck: implications in Hodgkin's lymphoma. Cancer Res. 2006;66:1114–1122
  53. Holla VR, Mann JR, Shi Q, DuBois RN. Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer. J. Biol. Chem. 2006;281:2676–2682
  54. Zatelli MC, Luchin A, Piccin D, Tagliati F, Bottoni A, Vignali C, et al. Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism. J. Clin Endocrinol. Metab. 2005;90:5754–5760
  55. Bren-Mattison Y, Meyer AM, Van Putten V, Li H, Kuhn K, Stearman R, et al. Antitumorigenic effects of peroxisome proliferator-activated receptor-gamma in non-small-cell lung cancer cells are mediated by suppression of cyclooxygenase-2 via inhibition of nuclear factor-kappaB. Mol. Pharmacol. 2008;73:709–717
  56. Yuan XL, Chen L, Li MX, Dong P, Xue J, Wang J, et al. Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. Clin. Immunol. 2010;134:277–288
  57. Takahashi H, Li A, Dawson DW, Hines OJ, Reber HA, Eibl G. Cyclooxygenase-2 confers growth advantage to syngeneic pancreatic cancer cells. Pancreas. 2011;40:453–459
  58. Judson BL, Miyaki A, Kekatpure VD, Du B, Gilleaudeau P, Sullivan-Whalen M, et al. U.V. radiation inhibits 15-hydroxyprostaglandin dehydrogenase levels in human skin: evidence of transcriptional suppression. Cancer Prev. Res. (Phila.). 2010;3:1104–1111
  59. Kim JI, Lakshmikanthan V, Frilot N, Daaka Y. Prostaglandin E2 promotes lung cancer cell migration via EP4-betaArrestin1-c-Src signalsome. Mol. Cancer Res. 2010;8:569–577
  60. De Bacco F, Luraghi P, Medico E, Reato G, Girolami F, Perera T, et al. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer. J. Natl. Cancer Inst. 2011;103:645–661
  61. Skouteris GG, Schröder CH. Cytosolic phospholipase A2 is activated by the hepatocyte growth factor receptor-kinase in Madin Darby canine kidney cells. J. Cell Sci. 1997;110(Pt 14):1655–1663
  62. Rieke C, Kähne T, Schweitzer K, Schraven B, Wienands J, Engelke M, et al. Non-T cell activation linker regulates ERK activation in Helicobacter pylori-infected epithelial cells. Cell Signal. 2010;22:395–403
  63. Zhu H, Naujokas MA, Park M. Receptor chimeras indicate that the met tyrosine kinase mediates the motility and morphogenic responses of hepatocyte growth/scatter factor. Cell Growth Differ. 1994;5:359–366
  64. Pai R, Nakamura T, Moon WS, Tarnawski AS. Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors. FASEB J. 2003;17:1640–1647
  65. Han C, Michalopoulos GK, Wu T. Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells. J. Cell Physiol. 2006;207:261–270
  66. Buchanan FG, Wang D, Bargiacchi F, DuBois RN. Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J. Biol. Chem. 2003;278:35451–35457
  67. Bai XM, Jiang H, Ding JX, Peng T, Ma J, Wang YH, et al. Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells. Life Sci. 2010;86:214–223
  68. Moore AE, Greenhough A, Roberts HR, Hicks DJ, Patsos HA, Williams AC, et al. HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells. Carcinogenesis. 2009;30:1796–1804
  69. Skouteris GG, Schröder CH. The hepatocyte growth factor receptor kinase-mediated phosphorylation of lipocortin-1 transduces the proliferating signal of the hepatocyte growth factor. J. Biol. Chem. 1996;271:27266–27273
  70. Comba A, Maestri DM, Berra MA, Garcia CP, Das UN, Eynard AR, et al. Effect of ω-3 and ω-9 fatty acid rich oils on lipoxygenases and cyclooxygenases enzymes and on the growth of a mammary adenocarcinoma model. Lipids Health Dis. 2010;9:112
  71. Sangeetha PS, Das UN. Gamma-linolenic acid and eicosapentaenoic acid potentiate the cytotoxicity of anti-cancer drugs on human cervical carcinoma (HeLa) cells in vitro. Med. Sci Res. 1993;21:457–459
  72. Madhavi N, Das UN. Reversal of KB-3-1 and KB-Ch-8-5 tumor cell drug-resistance by cis-unsaturated fatty acids in vitro. Med. Sci Res. 1994;22:689–692
  73. Das UN, Madhavi N, Padma M, Sagar PS. Can tumor cell drug-resistance be reversed by essential fatty acids and their metabolites?. Prostaglandins Leukotr. Essen. Fatty Acids. 1998;58:39–54
  74. Vartak S, Robbins ME, Spector AA. Polyunsaturated fatty acids increase the sensitivity of 36B10 rat astrocytoma cells to radiation-induced cell kill. Lipids. 1997;32:283–292
  75. Germain E, Chajès V, Cognault S, Lhuillery C, Bougnoux P. Enhancement of doxorubicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231: relationship to lipid peroxidation. Int. J. Cancer. 1998;75:578–583
  76. Mahéo K, Vibet S, Steghens JP, Dartigeas C, Lehman M, Bougnoux P, et al. Differential sensitization of cancer cells to doxorubicin by DHA: a role for lipoperoxidation. Free Radic. Biol. Med. 2005;39:742–751
  77. Menendez JA, Ropero S, Lupu R, Colomer R. Omega-6 polyunsaturated fatty acid gamma-linolenic acid (18:3n-6) enhances docetaxel (Taxotere) cytotoxicity in human breast carcinoma cells: relationship to lipid peroxidation and HER-2/neu expression. Oncol. Rep. 2004;11:1241–1252
  78. Menéndez JA, Ropero S, del Barbacid MM, Montero S, Solanas M, Escrich E, et al. Synergistic interaction between vinorelbine and gamma-linolenic acid in breast cancer cells. Breast Cancer Res. Treat. 2002;72:203–219
  79. Kong X, Ge H, Chen L, Liu Z, Yin Z, Li P, et al. Gamma-linolenic acid modulates the response of multidrug-resistant K562 leukemic cells to anticancer drugs. Toxicol. In Vitro. 2009;23:634–639
  80. Das UN, Rao KP. Effect of gamma-linolenic acid and prostaglandins E1 on gamma-radiation and chemical-induced genetic damage to the bone marrow cells of mice. Prostaglandins Leukot. Essent. Fatty Acids. 2006;74:165–173
  81. Koratkar R, Das UN, Sagar PS, Ramesh G, Padma M, Kumar GS, et al. Prostacyclin is a potent anti-mutagen. Prostaglandins Leukot. Essent. Fatty Acids. 1993;48:175–184
  82. Oon BB, Muggleston D, Warley A. A diet enriched in essential fatty acids protects against the loss of lymphocytes which occurs in rats suffering from streptozotocin-induced diabetes. Exp. Physiol. 1992;77:185–190
  83. Fritz KL, Nelson TL, Ruiz-Velasco V, Mercurio SD. Acute intramuscular injection of oils or the oleic acid component protects mice against paraquat lethality. J. Nutr. 1994;124:425–429
  84. Price SA, Hounsom L, Purves-Tyson TD, Fernyhough P, Tomlinson DR. Activation of JNK in sensory neurons protects against sensory neuron cell death in diabetes and on exposure to glucose/oxidative stress in vitro. Ann. N Y Acad. Sci. 2003;1010:95–99
  85. Das UN, Devi GR, Rao KP, Rao MS. Prostaglandins and their precursors can modify genetic damage induced by benzo (a,) pyrene and gamma-radiation. Prostaglandins. 1985;29:911–920
  86. Sridevi K, Rao KP, Das UN. Modification of benzo (a) pyrene induced genetic damage by prostaglandin E1: a dose response and time course study. Med. Sci. Res. 1990;18:473–474
  87. Das UN, Rao KP. Effect of γ-linolenic acid and prostaglandins E1 on gamma-radiation and chemical-induced genetic damage to the bone marrow cells of mice. Prostaglandins Leukot. Essen. Fatty Acids. 2006;74:165–173
  88. Shivani P, Rao KP, Chaudhury JR, Ahmed J, Rao BR, Kanjilal S, et al. Effect of polyunsaturated fatty acids on diphenyl hydantoin-induced genetic damage in vitro and in vivo. Prostaglandins Leukot. Essent. Fatty Acids. 2009;80:43–50
  89. Devi GR, Das UN, et al. Prostaglandins and mutagenesis: Prevention and/or reversibility of genetic damage induced by benzo (a) pyrene in the bone marrow cells of mice by prostaglandins El. Prostaglandins Leukotrienes Med. 1984;15:287–1984
  90. Das UN, Ramadevi G, Rao KP, Rao MS. Prostaglandins can modify gamma-radiation and chemical-induced cytotoxicity and genetic damage in vitro and in vivo. Prostaglandins. 1989;38:689–716
  91. Das UN, Begin ME, Ells G. Precursors of prostaglandins and other n-6 essential fatty acids can modify benzo(a)pyrene-induced chromosomal damage to human lymphocytes in vitro. Nutr. Rep. Int. 1987;36:1267–1271
  92. Das UN, Devi GR, Rao KP, Rao MS. Benzo(a)pyrene and gamma-radiation-induced genetic damage in mice can be prevented by gamma-linolenic acid but not by arachidonic acid. Nutr. Res. 1985;5:101–106
  93. Sailaja Devi MM, Das UN. Effect of prostaglandins against alloxan-induced cytotoxicity to insulin secreting insulinoma RIN cells in vitro. Prostaglandins Leukot. Essent. Fatty Acids. 2004;71:309–318
  94. Sailaja MMS, Das UN. Effect of prostaglandins against alloxan-induced diabetes mellitus. Prostaglandins Leukot. Essent. Fatty Acids. 2006;74:39–60
  95. Suresh Y, Das UN. Long-chain polyunsaturated fatty acids and chemically-induced diabetes mellitus: effect of ω-6 fatty acids. Nutrition. 2003;19:93–114
  96. Suresh Y, Das UN. Long-chain polyunsaturated fatty acids and chemically-induced diabetes mellitus: effect of ω-3 fatty acids. Nutrition. 2003;19:213–228
  97. Das UN, Madhavi N. Effect of polyunsaturated fatty acids on drug-sensitive and resistant tumor cells in vitro. Lipids Health Dis. 2011;10:159
  98. Manjari V, Das UN. Oxidant stress, anti-oxidants, nitric oxide and essential fatty acids in peptic ulcer disease. Prostaglandins Leukot. Essent. Fatty Acids. 1998;59:401–406
  99. Manjari V, Das UN. Effect of polyunsaturated fatty acids on dexamethasone-induced gastric mucosal damage. Prostaglandins Leukot. Essent. Fatty Acids. 2000;62:85–96
  100. Das UN. Cis-unsaturated fatty acids as potential anti-peptic ulcer drugs. Prostaglandins Leukot. Essent. Fatty Acids. 1998;58:377–380
  101. Das UN. Molecular Basis of Health and Disease. New York: Springer; 2011;
  102. Chan MM, Moore AR. Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production. J. Immunol. 2010;184:6418–6426
  103. Karim MJ, Bhattacherjee P, Biswas S, Paterson CA. Anti-inflammatory effects of lipoxins on lipopolysaccharide-induced uveitis in rats. J. Ocul. Pharmacol. Ther. 2009;25:483–486
  104. Kure I, Nishiumi S, Nishitani Y, Tanoue T, Ishida T, Mizuno M, et al. Lipoxin A(4) reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-kappaB activation. J. Pharmacol. Exp. Ther. 2010;332:541–548
  105. Wu SH, Liu B, Dong L, Wu HJ. NF-kappaB is involved in inhibition of lipoxin A4 on dermal inflammation and hyperplasia induced by mezerein. Exp. Dermatol. 2010;19:e286–e288
  106. Kim SJ. Lipoxins formation by rat basophilic leukemia (RBL-1) cells. Res. Commun. Chem. Pathol. Pharmacol. 1990;68:159–174
  107. Stenke L, Näsman-Glaser B, Edenius C, Samuelsson J, Palmblad J, Lindgren JA. Lipoxygenase products in myeloproliferative disorders: increased leukotriene C4 and decreased lipoxin formation in chronic myeloid leukemia. Adv. Prostaglandin Thromboxane Leukot. Res. 1991;21B:883–886
  108. Stenke L, Edenius C, Samuelsson J, Lindgren JA. Deficient lipoxin synthesis: a novel platelet dysfunction in myeloproliferative disorders with special reference to blastic crisis of chronic myelogenous leukemia. Blood. 1991;78:2989–2995
  109. Chen Y, Hao H, He S, Cai L, Li Y, Hu S, et al. Lipoxin A4 and its analogue suppress the tumor growth of transplanted H22 in mice: the role of antiangiogenesis. Mol. Cancer Ther. 2010;9:2164–2174
  110. Zhang B, Jia H, Liu J, Yang Z, Jiang T, Tang K, et al. Depletion of regulatory T cells facilitates growth of established tumors: a mechanism involving the regulation of myeloid-derived suppressor cells by lipoxin A4. J. Immunol. 2010;185:7199–7206
  111. Gleissman H, Yang R, Martinod K, Lindskog M, Serhan CN, Johnsen JI, et al. Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates. FASEB J. 2010;24:906–915
  112. Gleissman H, Segerström L, Hamberg M, Ponthan F, Lindskog M, Johnsen JI, et al. Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo. Int. J. Cancer. 2011;128:1703–1711
  113. Rose DP, Connolly JM, Coleman M. Effect of omega-3 fatty acids on the progression of metastases after the surgical excision of human breast cancer cell solid tumors growing in nude mice. Clin. Cancer Res. 1996;2:1751–1756
  114. Jin Y, Arita M, Zhang Q, Saban DR, Chauhan SK, Chiang N, et al. Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. Invest. Ophthalmol. Vis. Sci. 2009;50:4743–4752
  115. Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, Yang R, et al. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc. Natl. Acad. Sci. U S A. 2010;107:1660–1665
  116. Nicolaou A, Pilkington SM, Rhodes LE. Ultraviolet-radiation induced skin inflammation: dissecting the role of bioactive lipids. Chem. Phys. Lipids. 2011;164:535–543
  117. Takahashi M, Przetakiewicz M, Ong A, Borek C, Lowenstein JM. Effect of w3 and w6 fatty acids on transformation of cultured cells by irradiation and transfection. Cancer Res. 1992;52:154–162
  118. Das UN. Essential fatty acids and their metabolites as modulators of stem cell biology. Agro FOOD Indus. Hi-tech. 2010;21:2–3
  119. Das UN. Influence of polyunsaturated fatty acids and their metabolites on stem cell biology. Nutrition. 2011;27:21–25
  120. Hoggatt J, Pelus LM. Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor trafficking. Leukemia. 2010;24:1993–2002
  121. Hoggatt J, Singh P, Sampath J, Pelus LM. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood. 2009;113:5444–5455
  122. F. Li, Q. Huang, J. Chen, Y. Peng, D. Roop, J.S. Bedford, C.-Y. Li. Apoptotic cells activate the “Phoenix Rising” pathway to promote wound healing and tissue regeneration. Sci. Signal 3(110): ra13. doi:10.1126/scisignal.2000634.
  123. Biteman B, Hassan IR, Walker E, Leedom AJ, Dunn M, Seta F, et al. Interdependence of lipoxin A4 and heme-oxygenase in counter-regulating inflammation during corneal wound healing. FASEB J. 2007;21:2257–2266
  124. Tang DG, Chen YQ, Honn KV. Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. Proc. Natl. Acad. Sci. U S A. 1996;93:5241–5246
  125. Wu SH, Lu C, Dong L, Zhou GP, He ZG, Chen ZQ. High dose of lipoxin A4 induces apoptosis in rat renal interstitial fibroblasts. Prostaglandins Leukot. Essent. Fatty Acids. 2005;73:127–137
  126. Prieto P, Cuenca J, Través PG, Fernández-Velasco M, Martín-Sanz P, Boscá L. Lipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3K/Akt and the ERK/Nrf-2 defense pathways. Cell Death Differ. 2010;17:1179–1188
  127. El Kebir D, József L, Khreiss T, Pan W, Petasis NA, Serhan CN, et al. Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation. J. Immunol. 2007;179:616–622
  128. Markosyan N, Chen EP, Ndong VN, Yao Y, Sterner CJ, Chodosh LA, et al. Deletion of cyclooxygenase 2 in mouse mammary epithelial cells delays breast cancer onset through augmentation of type 1 immune responses in tumors. Carcinogenesis. 2011;32:1441–1449

PII: S0952-3278(11)00142-6

doi: 10.1016/j.plefa.2011.09.008

Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 86, Issue 1 , Pages 3-11 , January 2012

Article Tools

* Image Usage & Resolution